New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.

Article Details

Citation

Copy to clipboard

Queener SF

New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.

J Med Chem. 1995 Nov 24;38(24):4739-59.

PubMed ID

7490723 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Binding Properties

Drug	Target	Property	Measurement	pH	Temperature (°C)
Piritrexim	Dihydrofolate reductase	IC 50 (nM)	31	N/A	N/A	Details